Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in miceEriya Kenjo(Takeda (Japan)), Akitsu Hotta(Kyoto University)Nature CommunicationsDecember 8, 202110.1038/s41467-021-26714-wCited by 277SaveCiteExport RISWatch citationsRelated PapersExtracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping|Nature Communications|2020|359Efficient ssODN-Mediated Targeting by Avoiding Cellular Inhibitory RNAs through Precomplexed CRISPR-Cas9/sgRNA Ribonucleoprotein|Stem Cell Reports|2021|51